MPLX LP vs BIO-TECHNE Corp — how do they compare? MPLX LP trades at $56.75 (market cap $57.97B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: MPLX LP is far larger — about 5.2× BIO-TECHNE Corp's market cap, and MPLX LP pays the higher dividend (7.54%). Which is the better fit depends on your goals.
| MPLX | TECH | |
|---|---|---|
Market Cap | $57.97B | $11.16B |
Sector | Technology | Health |
52-Week High | $59.17 | $72.12 |
52-Week Low | $47.80 | $43.31 |
Enterprise Value | $82.60B | $11.24B |
Dividend Yield | 7.54% | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →